Migraine  	Migraine  	 NNP	O
and  	and  	 CC	O
central  	central  	 JJ	O
sensitization 	sensitization 	 NN	B-NP
:  	:  	 :	O
clinical  	clinical  	 JJ	B-NP
features 	features 	 NNS	I-NP
,  	,  	 ,	O
main  	main  	 JJ	O
comorbidities  	comorbidities  	 NN	B-NP
and  	and  	 CC	O
therapeutic  	therapeutic  	 JJ	B-NP
perspectives  	perspectives  	 JJ	I-NP
BACKGROUND  	BACKGROUND  	 NNP	I-NP
Migraine  	Migraine  	 NNP	I-NP
is  	is  	 VBZ	O
a  	a  	 DT	O
disorder  	disorder  	 NN	O
of  	of  	 IN	O
neuro-vascular  	neuro-vascular  	 JJ	B-NP
origin 	origin 	 NN	I-NP
,  	,  	 ,	O
being  	being  	 VBG	O
amongst  	amongst  	 IN	O
the  	the  	 DT	O
20  	20  	 CD	O
most  	most  	 RBS	O
disabling  	disabling  	 JJ	O
disease 	disease 	 NN	O
.  	.  	 .	O
Migraine  	Migraine  	 JJ	B-NP
attacks  	attacks  	 NNS	I-NP
are  	are  	 VBP	O
characterized  	characterized  	 VBN	O
by  	by  	 IN	O
severe  	severe  	 JJ	O
throbbing  	throbbing  	 JJ	O
headache 	headache 	 NN	O
,  	,  	 ,	O
associated  	associated  	 VBN	O
to  	to  	 TO	O
nausea 	nausea 	 VB	O
,  	,  	 ,	O
vomiting 	vomiting 	 NN	O
,  	,  	 ,	O
photophobia 	photophobia 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
phonophobia 	phonophobia 	 NN	B-NP
.  	.  	 .	O
PATHOPHYSIOLOGY  	PATHOPHYSIOLOGY  	 NNP	B-NP
AND  	AND  	 CC	O
ROLE  	ROLE  	 NNP	O
OF  	OF  	 IN	O
CENTRAL  	CENTRAL  	 NNP	O
SENSITIZATION  	SENSITIZATION  	 NNP	B-NP
Abnormal  	Abnormal  	 NNP	I-NP
neuronal  	neuronal  	 NN	I-NP
excitability  	excitability  	 NNS	I-NP
may  	may  	 MD	O
subtend  	subtend  	 VB	O
altered  	altered  	 VBN	O
processing  	processing  	 NN	O
of  	of  	 IN	O
sensory  	sensory  	 JJ	B-NP
stimuli 	stimuli 	 NNS	I-NP
,  	,  	 ,	O
leading  	leading  	 VBG	O
to  	to  	 TO	O
cortical  	cortical  	 VB	O
spreading  	spreading  	 VBG	B-NP
depression  	depression  	 NN	I-NP
and  	and  	 CC	O
trigeminal  	trigeminal  	 JJ	B-NP
activation 	activation 	 NN	I-NP
.  	.  	 .	O
A  	A  	 DT	O
dysfunction  	dysfunction  	 NN	B-NP
of  	of  	 IN	I-NP
pain  	pain  	 NN	I-NP
modulation  	modulation  	 NN	I-NP
enhances  	enhances  	 VBZ	O
central  	central  	 JJ	O
sensitization  	sensitization  	 JJ	B-NP
phenomena 	phenomena 	 NNS	I-NP
,  	,  	 ,	O
contributing  	contributing  	 VBG	O
to  	to  	 TO	O
acute  	acute  	 JJ	O
allodynia  	allodynia  	 NN	B-NP
and  	and  	 CC	O
headache  	headache  	 JJ	B-NP
persistence 	persistence 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
peculiarity  	peculiarity  	 NN	O
of  	of  	 IN	O
migraine  	migraine  	 JJ	B-NP
pain  	pain  	 NN	I-NP
facilitates  	facilitates  	 VBD	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
analgesics 	analgesics 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
causes  	causes  	 VBZ	O
an  	an  	 DT	O
adjunctive  	adjunctive  	 JJ	B-NP
invalidating  	invalidating  	 JJ	I-NP
tendency  	tendency  	 NN	I-NP
toward  	toward  	 IN	O
drug  	drug  	 NN	B-NP
over-use 	over-use 	 NN	I-NP
.  	.  	 .	O
COMORBIDITY  	COMORBIDITY  	 NNP	B-NP
Chronic  	Chronic  	 NNP	I-NP
migraine  	migraine  	 NN	I-NP
patients  	patients  	 NNS	I-NP
are  	are  	 VBP	O
frequently  	frequently  	 RB	O
affected  	affected  	 VBN	O
by  	by  	 IN	O
diffuse  	diffuse  	 JJ	O
pain 	pain 	 NN	O
,  	,  	 ,	O
framed  	framed  	 VBN	O
in  	in  	 IN	O
fibromyalgia  	fibromyalgia  	 JJ	B-NP
diagnosis 	diagnosis 	 NN	I-NP
.  	.  	 .	O
This  	This  	 DT	O
comorbidity  	comorbidity  	 NN	B-NP
seems  	seems  	 VBZ	O
to  	to  	 TO	O
be  	be  	 VB	O
supported  	supported  	 VBN	O
by  	by  	 IN	O
common  	common  	 JJ	O
pathophysiological  	pathophysiological  	 JJ	B-NP
mechanisms 	mechanisms 	 NNS	I-NP
.  	.  	 .	O
It  	It  	 PRP	O
may  	may  	 MD	O
aggravate  	aggravate  	 VB	O
migraine  	migraine  	 JJ	O
invalidity  	invalidity  	 NNS	O
being  	being  	 VBG	O
worth  	worth  	 NN	O
of  	of  	 IN	O
consideration  	consideration  	 NN	B-NP
for  	for  	 IN	I-NP
therapeutic  	therapeutic  	 JJ	I-NP
management 	management 	 NN	I-NP
.  	.  	 .	O
MIGRAINE  	MIGRAINE  	 NNP	B-NP
MANAGEMENT  	MANAGEMENT  	 NNP	I-NP
Acute  	Acute  	 NNP	I-NP
and  	and  	 CC	O
preventive  	preventive  	 JJ	B-NP
treatments  	treatments  	 NNS	I-NP
need  	need  	 VBP	O
to  	to  	 TO	O
be  	be  	 VB	O
tailored  	tailored  	 VBN	O
to  	to  	 TO	O
single  	single  	 JJ	O
cases 	cases 	 NNS	O
.  	.  	 .	O
Main  	Main  	 JJ	B-NP
comorbidity  	comorbidity  	 NN	I-NP
and  	and  	 CC	O
factors  	factors  	 NNS	O
facilitating  	facilitating  	 VBG	O
central  	central  	 JJ	O
sensitization  	sensitization  	 NN	B-NP
should  	should  	 MD	O
be  	be  	 VB	O
taken  	taken  	 VBN	O
into  	into  	 IN	O
account 	account 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
management  	management  	 NN	O
of  	of  	 IN	O
migraine  	migraine  	 JJ	O
patients  	patients  	 NNS	O
should  	should  	 MD	O
include  	include  	 VB	O
a  	a  	 DT	O
link  	link  	 NN	O
between  	between  	 IN	O
headache  	headache  	 JJ	B-NP
centers  	centers  	 NNS	I-NP
and  	and  	 CC	O
general  	general  	 JJ	O
practitioner  	practitioner  	 NN	B-NP
,  	,  	 ,	O
in  	in  	 IN	O
order  	order  	 NN	O
to  	to  	 TO	O
provide  	provide  	 VB	O
for  	for  	 IN	O
a  	a  	 DT	O
better  	better  	 RBR	O
patient  	patient  	 JJ	O
information  	information  	 NN	O
and  	and  	 CC	O
treatment  	treatment  	 NN	O
just  	just  	 RB	O
at  	at  	 IN	O
the  	the  	 DT	O
onset  	onset  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
disease 	disease 	 NN	O
.  	.  	 .	O
CONCLUSIONS  	CONCLUSIONS  	 NNS	O
Despite  	Despite  	 IN	O
its  	its  	 PRP$	O
high  	high  	 JJ	O
epidemiologic  	epidemiologic  	 JJ	B-NP
impact 	impact 	 NN	I-NP
,  	,  	 ,	O
migraine  	migraine  	 NN	O
is  	is  	 VBZ	O
frequently  	frequently  	 RB	O
underestimated  	underestimated  	 VBN	O
and  	and  	 CC	O
destined  	destined  	 VBN	O
to  	to  	 TO	O
evolve  	evolve  	 VB	O
into  	into  	 IN	O
chronic  	chronic  	 JJ	B-NP
form  	form  	 NN	I-NP
and  	and  	 CC	O
drugs  	drugs  	 NNS	B-NP
abuse 	abuse 	 NN	I-NP
.  	.  	 .	O
A  	A  	 DT	O
more  	more  	 RBR	O
focused  	focused  	 JJ	O
attention  	attention  	 NN	O
to  	to  	 TO	O
factors  	factors  	 NNS	O
facilitating  	facilitating  	 VBG	O
central  	central  	 JJ	O
sensitization  	sensitization  	 NN	B-NP
and  	and  	 CC	O
invalidating  	invalidating  	 JJ	O
comorbidities 	comorbidities 	 NN	B-NP
,  	,  	 ,	O
should  	should  	 MD	O
reduce  	reduce  	 VB	O
the  	the  	 DT	O
global  	global  	 JJ	O
burden  	burden  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
disease 	disease 	 NN	O
.  	.  	 .	O
